CAMP4 Therapeutics Corporation (CAMP)
(Delayed Data from NSDQ)
$2.28 USD
-0.22 (-8.80%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $2.27 -0.01 (-0.44%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CAMP 2.28 -0.22(-8.80%)
Will CAMP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CAMP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CAMP
Is CAMP preparing to trend higher? 1,2,3 Pullback Bullish shows up after plummeting 8.8%
Calm After Storm appears for CAMP after 3.47% move
CAMP forms 1,2,3 Pullback Bullish on September 18
Promising Prospects for CAMP4 Therapeutics: Buy Rating Affirmed Amid Advancements in CMP-SYNGAP-01 Program and Strong Investor Confidence
CAMP forms Hammer Candlestick on September 16